News
-
-
-
-
-
-
-
-
-
-
PRESS RELEASE
GBC AG Initiates Coverage on Marinomed Biotech AG – Buy Recommendation with Price Target of EUR 42.00
GBC AG initiates coverage on Marinomed Biotech AG with a Buy recommendation and EUR 42.00 price target. Focus on innovative Marinosolv® technology for immunological and inflammatory diseases